Publication Results (509)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• »

• The effectiveness of implementing a reminder system into routine clinical practice: does it increase postpartum screening in women with gestational diabetes?

  Shea AK, Shah BR, Clark HD, Malcolm J, Walker M, Karovitch A, Keely EJ. Chronic Dis Can. 2011; 31(2):58-64.

• The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario

  Tu K, Mamdani MM, Jacka RM, Forde NJ, Rothwell DM, Tu JV. CMAJ. 2003; 168(5):553-7.

• The impact of osteoarthritis on difficulty walking: a population-based study

  King LK, Kendzerska T, Waugh EJ, Hawker GA. Arthritis Care Res (Hoboken). 2018; 70(1):71-9. Epub 2017 May 17.

• Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data

  Lipscombe LL, Austin PC, Alessi-Severini S, Blackburn DF, Blais L, Bresee L, Filion KB, Kawasumi Y, Kurdyak P, Platt RW, Tamim H, Paterson JM. Schizophr Res. 2014;154(1-3):54-60. Epub 2014 Feb 24.

• Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease in men and women

  Ko DT, Wijeysundera HC, Udell JA, Vaccarino V, Austin PC, Guo H, Velianou JL, Lau K, Tu JV. Can J Cardiol. 2014; 30(7):820-6. Epub 2014 May 2.

• Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infections: a population-based study of older women and men with diabetes

  Lega IC, Bronskill SE, Campitelli MA, Guan J, Stall NM, Lam K, McCarthy LM, Gruneir A, Rochon PA. Diabetes Obes Metab. 2019; 21(11):2394-404. Epub 2019 Jul 2. DOI: https://doi.org/10.1111/dom.13820

• December 2019

  Report

  • First Nations and Diabetes in Ontario

  Infographics

  • Validation study of health administrative data algorithms to identify individuals experiencing homelessness and estimate population prevalence of homelessness in Ontario, Canada
  • Association of baclofen with encephalopathy in patients with chronic kidney disease
  • Long-term mortality in mothers of infants with neonatal abstinence syndrome: a population-based parallel-cohort study in England and Ontario, Canada
  • Rates of recognized pregnancy in women with disabilities in Ontario, Canada
  • Dying of amyotrophic lateral sclerosis: health care use and cost in the last year of life

  ICES in the News

  • Long-term mental health outcomes in mothers and siblings of children with cancer: a population-based matched cohort study
  • Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study
  • Cross-Canada differences in early-stage breast cancer treatment and acute-care use
  • Population impact of generic valsartan recall
  • Trends of intentional drug overdose among youth: a population-based cohort study

  You may also be interested in...

  • Interfacility patient sharing and clostridioides difficile infection incidence in the Ontario hospital system: a 13-year cohort study
  • The impact of air pollution on the incidence of diabetes and survival among prevalent diabetes cases
  • Comparison of cardiovascular risk factors and outcomes among practicing physicians vs the general population in Ontario, Canada
  • Real-world risk of cardiovascular outcomes associated with hypertriglyceridemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies
  • Avoidable mortality rates decrease but inequity gaps widen for marginalized neighborhoods: a population-based analysis in Ontario, Canada from 1993 to 2014

• Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results)

  Verma S, Mamdani MM, Al-Omran M, Melo M, Rouleau JL. J Am Soc Hypertens. 2007; 1(4):286-94.

• A multicenter observational study of incretin-based drugs and heart failure

  Filion KB, Azoulay L, Platt RW, Dahl M, Dormuth CR, Clemens KK, Hu N, Paterson JM, Targownik L, Turin TC, Udell JA, Ernst P; for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. N Engl J Med. 2016; 374(12):1145-54.

• Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study

  Liddy C, Singh J, Hogg W, Dahrouge S, Deri-Armstrong C, Russell G, Taljaard M, Akbari A, Wells G. BMC Cardiovasc Disord. 2012; 12:74. Epub 2012 Sep 12.

• Metformin use and all-cause and prostate cancer–specific mortality among men with diabetes

  Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N. J Clin Oncol. 2013; 31(25):3069-75. Epub 2013 Aug 5.

• The treatment of unrelated disorders in patients with chronic medical diseases

  Redelmeier DA, Siew H, Tan MA, Booth GL. N Engl J Med. 1998; 338(21):1516-20.

• Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study

  Yan AT, Koh M, Chan KK, Guo H, Alter DA, Austin PC, Tu JV, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2017; 69(12):1523-32.

• Quantifying the impact of obesity category on major chronic diseases in Canada

  Jiang Y, Chen Y, Manuel D, Morrison H, Mao Y; Obesity Working Group. ScientificWorldJournal. 2007; 7:1211-21.

• Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis

  Biswas A, Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, Alter DA. Ann Intern Med. 2015; 162(2):123-32. Epub 2015 Jan 20.

• Chronic disease prevalence in women and air pollution: a 30-year longitudinal cohort study

  To T, Zhu J, Villeneuve PJ, Simatovic J, Feldman L, Gao C, Williams D, Chen H, Weichenthal S, Wall C, Miller AB. Environ Int. 2015; 80:26-32. Epub 2015 Apr 6.

• Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events

  Krahn MD, Bremner KE, Luo J, Alibhai SM. Curr Oncol. 2014; 21(3):e457-65.

• Self-monitoring of blood glucose levels: evaluating the impact of a policy of quantity limits on test-strip use and costs

  Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Juurlink DN, Singh S, Mamdani MM. Can J Diabetes. 2016; 40(5):431-5. Epub 2016 May 17.

• Quality of primary care among individuals receiving treatment for opioid use disorder

  Spithoff S, Kiran T, Khuu W, Kahan M, Guan Q, Tadrous M, Leece P, Martins D, Gomes T. Can Fam Physician. 2019; 65(5):343-51. Epub 2019 May 1.

• Association between neighborhood walkability and predicted 10-year cardiovascular disease risk: the Cardiovascular Health in Ambulatory Care Research Team (CANHEART) cohort

  Howell NA, Tu JV, Moineddin R, Chu A, Booth GL. J Am Heart Assoc. 2019; 8:e013146. Epub 2019 Oct 31. DOI: https://doi.org/10.1161/JAHA.119.013146

• Risk modification for diabetic patients. Are other risk factors treated as diligently as glycemia?

  Shah BR, Mamdani M, Jaakkimainen L, Hux JE. Can J Clin Pharmacol. 2004; 11(2):e239-44. Epub 2004 Nov 10.

• Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style?

  Naylor CD, Sermer M, Chen E, Sykora K. JAMA. 1996; 275(15):1165-70.

• The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited

  Parker AB, Yusuf S, Naylor CD. Am Heart J. 2002; 144(6):941-7.

• Risk factors for cardiovascular disease in Canada

  Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(11):1249-59.

• Diabetic patients with prior specialist care have better glycaemic control than those with prior primary care

  Shah BR, Hux JE, Laupacis A, Mdcm BZ, Austin PC, van Walraven C. J Eval Clin Pract. 2005; 11(6):568-75.

• Medication use and survival in diabetic patients with kidney cancer: a population-based cohort study

  Nayan M, Macdonald EM, Juurlink DN, Austin PC, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN). Pharmacol Res. 2016; 113(2016):468-74. Epub 2016 Sep 24.

• Cardiovascular risk factor management performance in Canada and the United States: a systematic review

  Alabousi M, Abdullah P, Alter DA, Booth GL, Hogg W, Ko DT, Manuel DG, Farkouh ME, Tu JV, Udell JA. Can J Cardiol. 2017; 33(3):393-404.

• Self-monitoring of blood glucose: impact of quantity limits in public drug formularies on provincial costs across Canada

  Knowles SR, Lee K, Paterson JM, Shah BR, Mamdani MM, Juurlink DN, Gomes T. Can J Diabetes. 2017; 41(2):138-42. Epub 2016 Dec 15.

• Risk factors for posterior compared to anterior ischemic stroke: an observational study of the Registry of the Canadian Stroke Network

  Subramanian G, Silva J, Silver FL, Fang J, Kapral MK, Oczkowski W, Gould L, O'Donnell MJ; Investigators of the Registry of the Canadian Stroke Network. Neuroepidemiology. 2009; 33(1):12-6. Epub 2009 Mar 20.

• Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: a population-based study

  Ko DT, Guo H, Wijeysundera HC, Zia MI, Dzavik V, Chu MW, Fremes SE, Cohen EA, Tu JV. JACC Cardiovasc Interv. 2011; 4(9):965-73.

• Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report

  Muggah E, Graves E, Bennett C, Manuel DG. BMC Public Health. 2013; 13:16. Epub 2013 Jan 9.

• How does complementary private prescription drug insurance coverage affect seniors’ use of publicly funded medications?

  Allin S, Law MR, Laporte A. Health Policy. 2013; 110(2-3):147-55. Epub 2013 Mar 19.

• Pediatric insulin pump therapy: reflecting on the first 10 years of a universal funding program

  Shulman R, Miller FA, Stukel TA, Daneman D, Guttmann A. Healthc Q. 2017; 19(4):6-9.

• Estimating multimorbidity prevalence with the Canadian Chronic Disease Surveillance System

  Feely A, Lix LM, Reimer K. Health Promot Chronic Dis Prev Can. 2017; 37(7):215-22.

• Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study

  Al-Omran M, Tu JV, Johnston KW, Mamdani MM, Kucey DS. J Vasc Surg. 2003; 38(2):279-88.

• Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

  Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Diabetes Care. 2005; 28(3):600-6.

• The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends

  Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force. Hypertension. 2006; 47(1):22-8. Epub 2005 Dec 12.

• Outpatient gatifloxacin therapy and dysglycemia in older adults

  Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C, Dresser L, Low DE, Mamdani MM. N Engl J Med. 2006; 354(13):1352-61. Epub 2006 Mar 1.

• The relationship between need and capacity for multidisciplinary cardiovascular risk-reduction programs in Ontario

  Candido E, Richards JA, Oh P, Suskin N, Arthur HM, Fair T, Alter DA. Can J Cardiol. 2011; 27(2):200-7. Epub 2011 Mar 1.

• Co-morbid non-communicable diseases and associated health service use in African and Caribbean immigrants with HIV

  Masindi KI, Jembere N, Kendall CE, Burchell AN, Bayoumi AM, Loutfy M, Raboud J, Rourke SB, Luyombya H, Antoniou T. J Immigr Minor Health. 2018; 20(3):536-45. Epub 2017 Dec 5.

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• »